Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
- Bias Rating
10% Center
- Reliability
30% ReliableFair
- Policy Leaning
10% Center
- Politician Portrayal
-7% Negative
Continue For Free
Create your free account to see the in-depth bias analytics and more.
Continue
Continue
By creating an account, you agree to our Terms and Privacy Policy, and subscribe to email updates. Already a member: Log inBias Score Analysis
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Sentiments
24% Positive
- Liberal
- Conservative
Sentence | Sentiment | Bias |
---|---|---|
Unlock this feature by upgrading to the Pro plan. |
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely
Liberal
Very
Liberal
Moderately
Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately
Conservative
Very
Conservative
Extremely
Conservative
-100%
Liberal
100%
Conservative
Contributing sentiments towards policy:
57% : Coverage through Medicaid, meanwhile, has varied from state to state.57% : The nation's top health agency estimates as many as 3.5 million people on Medicare and 4 million on Medicaid could qualify for coverage of the drugs.
51% : It would benefit millions, but cost billionsThe rule announced Tuesday affects Medicaid, which provides health care coverage for roughly 70 million of the nation's poorest people, and Medicare, the health insurance program for about 67 million older Americans.
49% : It's not clear if Trump will support itThe drugs are popular -- with a majority of Americans telling health firm KFF in a poll earlier this year that Medicare should cover the drugs.
47% : But it's unclear if the proposal, which would not go into effect until after Trump takes office, will have support from his new administration -- including from Robert F. Kennedy Jr., an opponent of the drugs whom the president-elect has tapped to serve as head of HHS.
47% : Under the proposal, the Centers for Medicare and Medicaid Services, or CMS, would reinterpret the federal law, to consider the drugs as a treatment for obesity diseases.
43% : But research suggests far more people might qualify, with the Centers for Medicare and Medicaid Services estimating roughly 28 million people on Medicaid are considered obese.
40% : Rep. Brad Wenstrup, a Republican who sponsored a bill to have Medicare cover the weight-loss drugs, has argued that covering the drugs and other obesity treatments could save taxpayers in the long run.
39% : Medicare has been barred from covering them under a law that says the program cannot pay for weight-loss products.
38% : The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound for a large segment of Americans who are obese.
34% : Kennedy has railed against the idea of Medicare or Medicaid covering the drugs.
16% : Trump or Kennedy could ultimately ignore Biden's proposal and not implement it.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.